Valsasina B, Orsini P, Caruso M, Albanese C, Ciavolella A, Cucchi U, Fraietta I, Melillo N, Fiorentini F, Rizzi S, Salsa M, Isacchi A, Gasparri F
Mol Cancer Ther (2023), 22(12), 1465-1478
Home / Novel Thienoduocarmycin-Trastuzumab ADC Demonstrates Strong Antitumor Efficacy with Favorable Safety Profile in Preclinical Studies
Valsasina B, Orsini P, Caruso M, Albanese C, Ciavolella A, Cucchi U, Fraietta I, Melillo N, Fiorentini F, Rizzi S, Salsa M, Isacchi A, Gasparri F
Mol Cancer Ther (2023), 22(12), 1465-1478
Nerviano Medical Sciences S.r.l.
Viale Luigi Pasteur 10
20014 Nerviano (MI)
Italy
Share Capital: € 1,200,000.00
fully paid-in
Company subject to the management and coordination of NMS Group S.p.A.